In a low-glucose TME, tumor cells produce lactic acid through glycolysis, which is absorbed by Tregs via monocarboxylate transporter 1 (MCT1), facilitating NFAT1 translocation into the nucleus and upregulating PD-1 expression. Here, SLC16A1 is linked to neoplasm.